May 10, 2021

PFI & Kerry: Partnering to develop joint health technology

One of the world’s leading taste and nutrition company, Kerry has announced that it has agreed on a strategic licensing partnership with Pharma Foods International Co. Ltd. (PFI) for the development, application, and global sales of a joint health ingredient technology for functional foods and beverages, and dietary supplements.

Pharma Foods International, based in Kyoto, Japan, is a pioneer and leader in innovative ingredients developed from natural food origins for application into functional products, nutraceuticals, cosmetics and pharmaceuticals.

The partnership and licensing agreement provides Kerry access to the joint health technology developed by PFI through more than a decade of research. The ingredient promotes the natural production of hyaluronic acid, keeping joints lubricated and mobile and ultimately helping to reduce discomfort and stiffness in knee joints and providing benefit to people with osteoarthritis. As it is a water-soluble ingredient that has no impact to taste in formulation, it creates opportunities for functional food and beverage applications as well as dietary supplements. The ingredient has already been formulated into several products in the Japanese market and Kerry will be developing a brand positioning for the technology, supporting application and development and supplying the ingredient to customers across the world.

John Quilter, Vice President & General Manager for Kerry’s ProActive Health business said: “Our proprietary consumer research has revealed that consumers want healthy lifestyle products that also have a positive impact on bone and joint health. Today’s consumers are more informed about the ingredients in their functional products – with 56% reporting that they regularly research ingredients that can help improve health[1]. We are delighted  to partner with PFI, a leader in functional ingredient innovation, on this new joint health technology which will complement our portfolio of science-backed branded ingredients, including GanedenBC30® probiotic, Wellmune® yeast beta-glucan, and our most recent addition, Bio-K Plus® probiotics.”

Chief Executive Officer of Pharma Foods International, Dr Mujo Kim stated: “We are very pleased and excited to be working with Kerry. PFI has been researching and developing original unique materials for the global market and now that we have established a cooperative relationship with Kerry, we will be able to accelerate our global expansion. We expect strong synergies between PFI’s research capabilities and Kerry’s global commercial network.”

Related articles

Germinated oilseed hemp – the superfood, is entering the market

In Finland, plans to build up a superfood processing line based on germination by malting were published recently. After an EU consultation round, Golden Malt & Foodfarm were granted market authorization for their superfood processing line of germinated oilseed hemp. According to the recently arrived statement, hemp seeds that are germinated by malting are not

New Study With Wellmune® Further Supports the Ingredient’s Ability to Strengthen the Immune System in a Food or Beverage Application

IMMUNE SUPPORT IS MOST SOUGHT HEALTH GOAL

Immune system support is the most common reason for consumers to buy healthy lifestyle products, according to new global research. A survey by Wellmune®, a natural ingredient that is clinically proven to help strengthen the immune system, asked over 11,000 consumers in 14 global markets about their reasons for buying healthy lifestyle products.1 They were

Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: